Graft-versus-host disease: new directions for a persistent problem

Drobyski Wr, Johnson Bd, Truitt Rl, Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease Bone Marrow Transplantation. ,vol. 11, pp. 329- 336 ,(1993)

RA Clift, JA Bianco, FR Appelbaum, CD Buckner, JW Singer, L Bakke, WI Bensinger, RA Bowden, GB McDonald, M Schubert, A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation Blood. ,vol. 82, pp. 2025- 2030 ,(1993) , 10.1182/BLOOD.V82.7.2025.2025

RB Geller, AH Esa, WE Beschorner, CG Frondoza, GW Santos, AD Hess, Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat. Blood. ,vol. 74, pp. 1165- 1171 ,(1989) , 10.1182/BLOOD.V74.3.1165.1165

M W Harty, D A Pearson, M Sykes, V S Abraham, IL-2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activity. Journal of Immunology. ,vol. 150, pp. 197- 205 ,(1993)

Billingham Re, The biology of graft-versus-host reactions. Harvey Lectures. ,vol. 62, pp. 21- 78 ,(1966)

M J Kennedy, G B Vogelsang, R A Beveridge, E R Farmer, V Altomonte, A M Huelskamp, N E Davidson, Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. Journal of Clinical Oncology. ,vol. 11, pp. 478- 484 ,(1993) , 10.1200/JCO.1993.11.3.478

M J Kennedy, G B Vogelsang, R J Jones, E R Farmer, A D Hess, V Altomonte, A M Huelskamp, N E Davidson, Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. Journal of Clinical Oncology. ,vol. 12, pp. 249- 257 ,(1994) , 10.1200/JCO.1994.12.2.249

J. J. Trentin, Mortality and skin transplantability in x-irradiated mice receiving isologous, homologous or heterologous bone marrow. Experimental Biology and Medicine. ,vol. 92, pp. 688- 693 ,(1956) , 10.3181/00379727-92-22582

B. Ryffel, H. Deyssenroth, J. F. Borel, Cyclosporin A: effects on the mouse thymus. Inflammation Research. ,vol. 11, pp. 373- 379 ,(1981) , 10.1007/BF01982473

Nelson J. Chao, Gerhard M. Schmidt, Joyce C. Niland, Michael D. Amylon, Andrew C. Dagis, Gwynn D. Long, Auayporn P. Nademanee, Robert S. Negrin, Margaret R. O'Donnell, Pablo M. Parker, Eileen P. Smith, David S. Snyder, Anthony S. Stein, Ruby M. Wong, Karl G. Blume, Stephen J. Forman, Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host Disease The New England Journal of Medicine. ,vol. 329, pp. 1225- 1230 ,(1993) , 10.1056/NEJM199310213291703